Delayed Hypersensitivity in Psoriasis

Area of Science:

• Immunology
• Dermatology
• Cutaneous hypersensitivity

Background:

• Psoriasis is a chronic inflammatory skin condition.
• Immune system dysregulation is implicated in psoriasis pathogenesis.
• Cutaneous delayed-type hypersensitivity (DTH) responses are a key component of cell-mediated immunity.

Purpose of the Study:

• To investigate and compare the delayed-type hypersensitivity (DTH) responses in adult male psoriasis patients versus healthy volunteers.
• To assess the reactivity of psoriasis patients to a panel of common skin test antigens and irritants.

Main Methods:

• Skin testing was performed on 22 adult male patients with psoriasis and 100 healthy male volunteers.
• Antigens and irritants used included mumps skin antigen, candidin, coccidiodin, purified protein derivative (PPD), croton oil, and 2,4-dinitrochlorobenzene (DNCB).
• Histamine was used as a positive control for irritant reactions.

Main Results:

• Psoriasis patients exhibited comparable skin test responses to normal volunteers across most tested antigens (mumps, candidin, coccidiodin, PPD) and irritants (croton oil, histamine).
• A notable exception was observed with 2,4-dinitrochlorobenzene (DNCB), where psoriasis patients demonstrated significantly decreased sensitization compared to controls.
• This finding suggests a specific impairment in DNCB-induced contact hypersensitivity in individuals with psoriasis.

Conclusions:

• The study indicates that while overall cell-mediated immunity assessed by standard skin tests is largely intact in psoriasis patients, there is a specific defect in contact hypersensitivity to DNCB.
• This selective anergy to DNCB warrants further investigation into the underlying immunological mechanisms in psoriasis.
• Findings suggest that DTH responses to common recall antigens are generally preserved in psoriasis patients.